He served as Laboratory Director at biotech company, Prosetta Corporation, leading
several small molecule drug discovery programs focused on viruses of interest to the United States Department of Defense.
Alternatively, once the down stream targets of Rett's silencing effect have been determined, phamra companies have
several tools in their arsenal to treat the disease, from
small molecule drugs to RNAi.